We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

45 hedge funds and large institutions have $26M invested in Abeona Therapeutics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

5% more funds holding

Funds holding: 43 → 45 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less capital invested

Capital invested by funds: $30.1M → $26M (-$4.14M)

Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
14
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$973K
2
GP
GLG Partners
United Kingdom
+$518K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$166K
4
Goldman Sachs
Goldman Sachs
New York
+$89.2K
5
NI
Numeric Investors
Massachusetts
+$86.1K

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$451K
2
SM
Sabby Management
Florida
-$163K
3
Millennium Management
Millennium Management
New York
-$139K
4
Morgan Stanley
Morgan Stanley
New York
-$102K
5
WMSA
Weiss Multi-Strategy Advisers
New York
-$101K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$52K – – –
Charles Schwab
27
Charles Schwab
California
$50K – – –
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$44K +$52.2K +520 New
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$41K +$49.2K +491 New
Morgan Stanley
30
Morgan Stanley
New York
$39K -$102K -1,013 -68%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$32K – – –
NFA
32
Nationwide Fund Advisors
Ohio
$22K – – –
AIG
33
American International Group
New York
$20K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$19K +$22.5K +224 New
Citigroup
35
Citigroup
New York
$12K +$13.9K +139 New
BA
36
BlackRock Advisors
Delaware
$9K -$9.83K -98 -47%
Deutsche Bank
37
Deutsche Bank
Germany
$9K -$1.3K -13 -10%
Bank of America
38
Bank of America
North Carolina
$8K +$903 +9 +11%
Creative Planning
39
Creative Planning
Kansas
$8K +$8.02K +80 +500%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$7.02K -$1.91K -19 -18%
LTFS
41
Ladenburg Thalmann Financial Services
Florida
$3K – – –
UBS Group
42
UBS Group
Switzerland
$2K +$2.31K +23 New
Wells Fargo
43
Wells Fargo
California
$1K +$301 +3 +30%
CG
44
Cutler Group
California
$1K +$2.01K +20 New
ACP
45
Acuta Capital Partners
California
– -$451K -4,454 Closed
Millennium Management
46
Millennium Management
New York
– -$139K -1,371 Closed
WMSA
47
Weiss Multi-Strategy Advisers
New York
– -$101K -1,000 Closed
CS
48
Credit Suisse
Switzerland
– -$52K -513 Closed
Group One Trading
49
Group One Trading
Illinois
– -$22K -215 Closed
Walleye Trading
50
Walleye Trading
New York
– -$7K -72 Closed
1
2
3

ABEO Hedge Fund Activity: Q4 2015 in Review

45 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2015, worth a combined $26M — down 14% from $30.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ABEO positions and 8 closed out — a net gain of 2 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was Royce & Associates, adding an estimated $973K. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $451K sold.

  • 45 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2015, up from 43 in Q3 2015.
  • Funds reported $26M of Abeona Therapeutics stock for Q4 2015, down 14% quarter-over-quarter.
  • 10 funds opened new Abeona Therapeutics positions in Q4 2015 and 8 closed out, a net change of +2 holders.
  • The largest Abeona Therapeutics buyer in Q4 2015 was Royce & Associates, an estimated $973K added.
  • The largest Abeona Therapeutics seller in Q4 2015 was Acuta Capital Partners, an estimated $451K sold.

Based on aggregated 13F filings for Q4 2015.